To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The California business aims to ...

Shares of a Chapel Hill company plunged nearly 90% Monday after the drug developer reported a late-stage clinical study missed its primary goal.

Researchers in India analyzed decades of data to reveal who's most at risk, and how to try to reduce the deadly toll.

Online aviation tracking shows the ER-2 plane flew back and forth over B.C.’s southern Interior more than a dozen times on Saturday ...

It's good news for parents and teens looking into trans-supportive healthcare.

CS is a highly morbid, chronic, and disfiguring condition with no approved therapiesBrepocitinib is the first investigational therapy to generate a positive result in a placebo-controlled CS study (Ph ...

A new study of Canadian adolescents who were referred to pediatric gender clinics is now part of a growing body of evidence showing that rates of “detransition” are remarkably low. An overwhelming ...

The following is the first story of a two-part series examining black lung disease rate in Appalachia. The story was ...

The Trump administration has long pushed a discredited link between vaccines and autism.

The City of Dubuque’s Parks and Recreation Department will host an upcoming virtual community workshop as part of the city’s ...

This video unveils the journey of Jeremy Ashkenas, a forgotten developer who revolutionized JavaScript in the face of overwhelming odds. Discover how his innovative solutions transformed a struggling ...

Road deaths are declining in the U.S. and worldwide, but lower-income countries aren’t experiencing much of the improvement, ...